Paper Spotlight: Altos Labs’ Quest for Immortality - Dr. Blagosklonny’s Perspective



May 11, 2022

Oncoscience published this trending research perspective in Volume 9, 2022, entitled, "Altos Labs and the quest for immortality: but can we live longer right now?" by Dr. Mikhail V. Blagosklonny from Roswell Park Cancer Institute, Buffalo, NY. DOI - Corresponding author - Mikhail V. Blagosklonny -, Abstract Some visionaries prefer to dream of immortality rather than to actually live longer. Here I discuss how combining rapamycin with other modalities may let us live long enough to benefit from future discoveries in cellular reprogramming and what needs to be done at Altos Labs to make this happen. Press release - Keywords - aging, longevity, lifespan, geroscience, rapalogs, gerostatics About Oncoscience Oncoscience's mission is to cover the rapidly growing field of cancer research. It’s aim is to focus on emergent topics not currently covered by other journals. Launched in 2014, Oncoscience is a peer-reviewed, traditional-style, bi-monthly journal with free access. Oncoscience also has a special mission: freeing researchers in oncology from publication costs. It is free for both readers and authors. Please visit our website at​ and connect with us: Facebook - Twitter - LinkedIn - YouTube - Oncoscience is published by Impact Journals, LLC:​​ Media Contact 18009220957 MEDIA@IMPACTJOURNALS.COM

Analytical TechniquesBiopharmaCell ScienceDrug Discovery

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.